儿童复杂髋关节重建手术加速康复路径的经济与临床影响
本研究纳入85例接受复杂髋关节重建手术的青少年患者进入加速康复路径,并与既往110例类似手术患者比较。主要结局为围术期阿片类药物消耗总量,次要结局包括住院时间、术后恶心、术中失血及费用。分段回归分析显示,路径实施本身未显著改变围术期阿片消耗的原有下降趋势,但临床、实验室、药房、手术室及总费用与路径实施显著相关。
要点
- 路径实施未显著改变围术期阿片消耗的原有下降趋势。
- 临床、实验室、药房、手术室及总费用与路径实施显著相关。
- 麻醉恢复室时间下降趋势在路径实施后显著趋平。
核心结论
- 该儿童加速康复路径对复杂髋关节重建青少年的影响与机构围术期指标的持续改善一致,但在实效环境中难以与其他举措和不断演变的实践模式的影响区分。
- 加速康复路径有助于将新的护理模式编纂和组织化,促进多学科循证护理模式并维持财务和临床指标原有的积极趋势。
研究设计与样本
- 主要结局为围术期阿片类药物消耗总量,次要结局包括住院时间、术后恶心、术中失血及其他围术期结局,并评估总护理费用和具体收费部门。
- 采用分段回归评估路径实施对结局的影响,并调整潜在混杂因素,包括实施前的时间趋势。
主要发现
- 路径实施前,平均围术期阿片消耗呈显著下降趋势(-0.10 mg总吗啡当量/90天;95%CI -0.20至0.00),若干次要围术期结局亦呈下降趋势。
- 无证据表明路径实施本身显著改变围术期阿片消耗的路径前趋势(即先前趋势持续)。
- 对于麻醉后监护室时间,下降趋势显著趋平(实施前:-5.25分钟/90天;95%CI -6.13至-4.36;实施后:1.04分钟/90天;95%CI -0.47至2.56;变化:6.29;95%CI 4.53-8.06)。
- 临床、实验室、药房、手术室和总费用与路径实施显著相关。
- 无证据表明路径实施显著改变其他次要结局的路径前趋势。
临床怎么用
- 该加速康复路径可帮助机构将新的围术期护理模式编纂和组织化,促进多学科循证护理。
- 在实效环境中评估加速康复路径效果时,需考虑原有时间趋势和其他并行举措的影响。
局限性
- 研究为实效性设计,路径影响难以与其他举措和不断演变的实践模式区分。
- 原文未明确报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery after surgery pathways confer significant perioperative benefits to patients and are currently well described for adult patients undergoing a variety of surgical procedures. Robust data to support enhanced recovery pathway use in children are relatively lacking in the medical literature, though clinical benefits are reported in targeted pediatric surgical populations. Surgery for complex hip pathology in the adolescent patient is painful, often requiring prolonged courses of opioid analgesia. Postoperative opioid-related side effects may lead to prolonged recovery periods and suboptimal postoperative physical function. Excessive opioid use in the perioperative period is also a major risk factor for the development of opioid misuse in adolescents. Perioperative opioid reduction strategies in this vulnerable population will help to mitigate this risk. METHODS: A total of 85 adolescents undergoing complex hip reconstructive surgery were enrolled into an enhanced recovery after surgery pathway (October 2015 to December 2018) and were compared with 110 patients undergoing similar procedures in previous years (March 2010 to September 2015). The primary outcome was total perioperative opioid consumption. Secondary outcomes included hospital length of stay, postoperative nausea, intraoperative blood loss, and other perioperative outcomes. Total cost of care and specific charge sectors were also assessed. Segmented regression was used to assess the effects of pathway implementation on outcomes, adjusting for potential confounders, including the preimplementation trend over time. RESULTS: Before pathway implementation, there was a significant downward trend over time in average perioperative opioid consumption (-0.10 mg total morphine equivalents/90 days; 95% confidence interval [CI], -0.20 to 0.00) and several secondary perioperative outcomes. However, there was no evidence that pathway implementation by itself significantly altered the prepathway trend in perioperative opioid consumption (ie, the preceding trend continued). For postanesthesia care unit time, the downward trend leveled off significantly (pre: -5.25 min/90 d; 95% CI, -6.13 to -4.36; post: 1.04 min/90 d; 95% CI, -0.47 to 2.56; Change: 6.29; 95% CI, 4.53-8.06). Clinical, laboratory, pharmacy, operating room, and total charges were significantly associated with pathway implementation. There was no evidence that pathway implementation significantly altered the prepathway trend in other secondary outcomes. CONCLUSIONS: The impacts of our pediatric enhanced recovery pathway for adolescents undergoing complex hip reconstruction are consistent with the ongoing improvement in perioperative metrics at our institution but are difficult to distinguish from the impacts of other initiatives and evolving practice patterns in a pragmatic setting. The ERAS pathway helped codify and organize this new pattern of care, promoting multidisciplinary evidence-based care patterns and sustaining positive preexisting trends in financial and clinical metrics.
引用
- Franklin AD, Sobey JH, Brenn BR, et al. Financial and Clinical Ramifications of Introducing a Novel Pediatric Enhanced Recovery After Surgery Pathway for Pediatric Complex Hip Reconstructive Surgery. Anesth Analg. 2021. PMID: 32665473. doi:10.1213/ANE.0000000000004980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。